SCHEMBL28624818

SCHEMBL28624818

O=[N+]([O-])c1ccc2c(c1)OC(c1ccccc1Cl)CN2

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 8/20 0.42
KMT2A Q03164 8/20 0.42
MAPT P10636 7/20 0.42
MEN1 O00255 6/20 0.42
LMNA P02545 2/20 0.41
KDM4E B2RXH2 1/20 0.41
L3MBTL1 Q9Y468 3/20 0.40
GAA P10253 2/20 0.40
HTT P42858 2/20 0.40
ALOX12 P18054 1/20 0.40
GABRP O00591 1/20 0.39
GABRD O14764 1/20 0.39
GABRA1 P14867 1/20 0.39
GABRB1 P18505 1/20 0.39
GABRG2 P18507 1/20 0.39
GABRB3 P28472 1/20 0.39
GABRA5 P31644 1/20 0.39
GABRA3 P34903 1/20 0.39
ADRA1A P35348 1/20 0.39
GABRA2 P47869 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5522362 0.74 ALDH1A1 (0.46) ALDH1A1KMT2AMAPTMEN1GAA
SCHEMBL5523199 0.72 KMT2A (0.47) ALDH1A1KMT2AMAPTMEN1GAA
SCHEMBL16064832 0.70 SLC6A3 (0.46) ALDH1A1KMT2AKDM4EHSD17B10HPGD
SCHEMBL10242244 0.70 SLC6A3 (0.46) ALDH1A1KMT2AKDM4EHSD17B10HPGD
SCHEMBL30943335 0.69 ALDH1A1 (0.39) ALDH1A1KMT2AMAPTMEN1LMNA
SCHEMBL29576353 0.68 ALDH1A1 (0.46) ALDH1A1KMT2AMAPTMEN1LMNA
SCHEMBL24042587 0.67 ALDH1A1 (0.52) ALDH1A1HTT
SCHEMBL27596768 0.67 CHRNB4 (0.49) ALDH1A1KMT2AMAPTMEN1L3MBTL1
SCHEMBL8991500 0.66 ALDH1A1 (0.46) ALDH1A1KMT2AMAPTMEN1LMNA
SCHEMBL8470484 0.66 MAPT (0.48) ALDH1A1KMT2AMAPTMEN1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12263159-B2 Fused ring compound having urea structure Sanford Burnham Prebys Medical Discovery Institute (US) 2025-04-01 US disclosed
US-20240285597-A1 FUSED RING COMPOUND HAVING UREA STRUCTURE DAIICHI SANKYO COMPANY LIMITED (JP) 2024-08-29 US disclosed
CN-112654608-B Fused ring compound having urea structure 桑福德伯纳姆普利斯医学发现研究所 2024-05-07 CN disclosed
CN-112654608-A Condensed ring compounds having urea structure 桑福德伯纳姆普利斯医学发现研究所 2021-04-13 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12263159-B2 Fused ring compound having urea structure NAMPT, NME4, NDUFAB1 ALDH1A1 1608/4885KMT2A 1263/4885MAPT 118/4885
US-20240285597-A1 FUSED RING COMPOUND HAVING UREA STRUCTURE NAMPT, NME4, NDUFAB1 ALDH1A1 1608/4885KMT2A 1263/4885MAPT 118/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.